First case of typical old world cutaneous leishmaniasis treated with miltefosine

International Journal of Dermatology

Volumn 46, Issue 4, 2007, Pages 385-387

  Stojkovic, Marija ^a,b,c   Junghanss, Thomas ^a,b,c   Krause, Eric ^a,b,c   Davidson, Robert N ^a,b,c  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b Northwick Park Hospital ^*  (Germany)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MILTEFOSINE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMASTIGOTE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AXILLARY LYMPH NODE; BODY WEIGHT; CASE REPORT; CLINICAL FEATURE; DRUG TOLERABILITY; FOLLOW UP; GERMANY; HUMAN; IMMUNOFLUORESCENCE TEST; INSECT BITE; LEISHMANIA MAJOR; LEISURE; LYMPHADENOPATHY; MALE; POLYMERASE CHAIN REACTION; SIDE EFFECT; SKIN BIOPSY; SKIN LEISHMANIASIS; SKIN ULCER; TRAVEL; TUNISIA;

ADMINISTRATION, ORAL; ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; DIAGNOSIS, DIFFERENTIAL; DNA, PROTOZOAN; HUMANS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MALE; PHOSPHORYLCHOLINE; POLYMERASE CHAIN REACTION;

EID: 34247127091     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03153.x     Document Type: Article

References (11)

1. Peters W. Heterogeneity of cutaneous leishmaniasis with emphasis on the Old World. Schweiz Med Wochenschrift 1993; 123: 1237-1249.
2. Davidson RN. Practical guide for the treatment of leishmaniasis. Drugs 1998; 56: 1009-1018.
3. Berman J. Current treatment approaches to leishmaniasis. Curr Opin Infect Dis 2003; 16: 397-401.
4. Reithinger R, Mohsen M, Wahid M, et al. Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by L. tropica in Kabul, Afghanistan: A randomised, controlled trial. Clin Infect Dis 2005; 40(8): 1148-1155.
5. Sundar S, Jha TK, Thakur CP, et al. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 2002; 347(22): 1739-1746.
6. Bhattacharya SK, Jha TK, Sundar S, et al. Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India. CID 2004; 38: 217-212.
7. Soto J, Arana A, Toledo J, et al. Miltefosine for New World cutaneous leishmaniasis. CID 2004; 38: 1266-1272.
8. BPI Service GmbH. Fachinformation Miltefosine. FachInfo. Fachinformationsverzeichnis Deutschland Ausgabe, 2005/01. Aulendorf: BPI Service GmbH, 2005.
9. Schraner C, Hasse B, Hasse U, et al. Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1. CID 2005; 40: 120-124.
10. Sterckx S. Patents and access to drugs in developing countries: An ethical analysis. Developing World Bioeth 2004; 4: 58-75.
11. Vega-Lopez F. Diagnosis of cutaneous leishmaniasis. Curr Opin Infect Dis 2003; 16: 97-101.